UCLA Researchers Map Tumor Cellular Neighborhoods to Predict Success of Combination Immunotherapy in Advanced Melanoma

UCLA study finds that the spatial organization of T cells and plasma cells in tumors predicts if melanoma patients will respond to combination immunotherapy.

By: AXL Media

Published: Apr 22, 2026, 4:18 AM EDT

Source: Information for this report was sourced from University of California - Los Angeles Health Sciences

Decoding the Spatial Architecture of Cancer Resistance

Advanced melanoma treatment has long relied on anti-PD-1 drugs to prime the immune system, yet many patients eventually experience disease progression as tumors develop resistance. When standard therapies fail, clinicians often introduce anti-CTLA-4 immunotherapy, though only 30% of patients derive a meaningful benefit. A groundbreaking study published in the journal Cancer Discovery suggests that the key to predicting this success lies in the physical geography of the tumor. By analyzing biopsies from the SWOG S1616 clinical trial, UCLA researchers found that the way immune cells are organized into "cellular neighborhoods" provides a more accurate forecast of treatment efficacy than traditional genetic sequencing.

The Role of T Cell Coordination in Tumor Shrinkage

In patients who responded successfully to the combination of ipilimumab and nivolumab, the researchers observed a highly organized immune attack. CD8 T cells, the body’s primary cancer-killing agents, were not only present but were strategically positioned to cluster directly around melanoma cells. These responders exhibited active immune signaling and the presence of diverse T cell populations that were actively dividing in close proximity to the malignancy. As the tumors began to regress, the study noted the arrival of supportive immune cells, including regulatory T cells and monocytes, which integrated into the tumor microenvironment to sustain the attack.

Plasma Cell Clusters as Indicators of Treatment Failure

Conversely, the study identified a specific structural pattern in non-responding tumors that appears to hinder the immune system. Tumors that continued to grow despite combination therapy often contained dense, localized clusters of plasma cells. These plasma cell-rich regions were consistently associated with suppressed T cell activity and a general failure of the immune system to penetrate the tumor core. This finding suggests that certain cellular neighborhoods within a tumor can create a sanctuary for cancer cells, effectively shielding them from the intended effects of immunotherapy and leading to a less effective immune response.